Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential
Full title: Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants...
top of page
Dec 20, 2022
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5
Full title: Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal...
Dec 9, 2022
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals ...
Full title: Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron...
Feb 24, 2022
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Nature Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, Péré...
bottom of page